Authors:
Jakus, V
Bauerova, K
Michalkova, D
Carsky, J
Citation: V. Jakus et al., Serum levels of advanced glycation end products in poorly metabolically controlled children with diabetes mellitus: Relation to HbA(1c), DIABET NUTR, 14(4), 2001, pp. 207-211
Authors:
Waczulikova, I
Sikurova, L
Bryszewska, M
Rekawiecka, K
Carsky, J
Ulicna, O
Citation: I. Waczulikova et al., Impaired erythrocyte transmembrane potential in diabetes mellitus and its possible improvement by resorcylidene aminoguanidine, BIOELECTRO, 52(2), 2000, pp. 251-256
Authors:
Waczulikova, I
Sikurova, L
Carsky, J
Strbova, L
Krahulec, B
Citation: I. Waczulikova et al., Decreased fluidity of isolated erythrocyte membranes in type 1 and type 2 diabetes. The effect of resorcylidene aminoguanidine, GEN PHYSL B, 19(4), 2000, pp. 381-392
Authors:
Sikurova, L
Dererova, J
Kvasnicka, P
Waczulikova, I
Carsky, J
Ulicna, O
Citation: L. Sikurova et al., Resorcylidene aminoguanidine improves the pathologically reduced fluidity of erythrocyte membranes in Diabetes mellitus, PHARMAZIE, 55(9), 2000, pp. 700-701
Authors:
Jakus, V
Hrnciarova, M
Carsky, J
Krahulec, B
Rietbrock, N
Citation: V. Jakus et al., Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant activity, LIFE SCI, 65(18-19), 1999, pp. 1991-1993
Authors:
Ziegelhoffer, A
Styk, J
Ravingerova, T
Sebokova, J
Volkovova, K
Waczulikova, I
Carsky, J
Dzurba, A
Docolomansky, P
Citation: A. Ziegelhoffer et al., Prevention of processes coupled with free radical formation prevents also the development of calcium-resistance in the diabetic heart, LIFE SCI, 65(18-19), 1999, pp. 1999-2001